NCT05951023View on ClinicalTrials.gov

Endotype-Targeted Therapy to Rescue OSA Patients Struggling with CPAP Adherence (TOP-CPAP)

PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Obstructive Sleep Apnea
Interventions
DRUG

Eszopiclone 2 mg

Eszopiclone tablet (encapsulated)

DRUG

Placebo

Sugar capsule manufactured to match encapsulated Eszopiclone

Trial Locations (1)

92121

RECRUITING

UC San Diego; Altman Clinical and Translational Research Institute Building, La Jolla

All Listed Sponsors
collaborator

American Academy of Sleep Medicine

OTHER

lead

University of California, San Diego

OTHER